THIO sequenced with Libtayo extended overall survival in those with non–small cell lung cancer who progressed on two or more standard-of-care regimens.

Susan Williams,seated center, a patient at the John B. Amos Cancer Center in Columbus, Georgia, is receiving a new cancer treatment known as Bispecific T-Cell Engager (BiTE) therapies on Feb. 11, 2025 ...

Many people with lung cancer develop anemia, especially after chemotherapy treatment. Anemia occurs when your red blood cell levels drop too low. In one 2021 study, about 32% of the people with ...

The integration of new technologies and treatment paradigms into the country’s health system each year enhances patients’ ...

In combination with fluoropyrimidine- and platinum-containing chemotherapy as first-line treatment for unresectable locally advanced or metastatic gastric or gastroesophageal junction (G/GEJ) ...

Guardant Health is overcoming skepticism with new cancer tests. Learn why GH stock is a buy, with strong growth and a shift ...

Bristol Myers Squibb said it is disappointed with the outcome of a study that examined whether one of its drugs could be used to treat a certain type of skin cancer. The drug, Opdualag, didn't meet ...

Ideaya Biosciences (IDYA) announced it has entered into an additional clinical study collaboration and supply agreement with Gilead Sciences ...

A Thunder Ridge High School student-athlete was recently diagnosed with cancer the same weekend as his 18th birthday. Tanner ...

The aim of surgery in stage 2 to 3b NSCLC patients is curative, but between a third and half of them will experience recurrence after surgery and need additional lines of treatment. Keytruda has ...

UBS has upgraded AstraZeneca (NASDAQ:AZN) to buy from neutral, stating it believes the company's in-market growth potential has been underestimated. The investment bank said its forecasts for the ...